Related Experiment Video
Updated: Jun 1, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Shogaols at proapoptotic concentrations induce G(2)/M arrest and aberrant mitotic cell death associated with tubulin
Fei-Fei Gan1, Amrita A Nagle, Xiaohui Ang
1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore 117543, Republic of Singapore.
Abstract:
Shogaols have been previously reported to induce cancer cell death via multiple mechanisms, among which one analog 6-shogaol has been reported to cause microtubule damage through specific reaction with sulfhydryl groups in tubulin. In this study, a series of shogaols with different side chain lengths (4-, 6-, 8- and 10-shogaol) was synthesized and evaluated for antiproliferative activity in HCT 116 colon carcinoma and SH-SY5Y neuroblastoma cells. 4- and 6-shogaol were identified as lead compounds possessing the strongest antiproliferative activity. In the soft agar assay, the lead shogaols displayed dose-dependent inhibition on cancer cell colony formation under anchorage-independent conditions. Using HCT 116 as the selected cancer cell line, the molecular events linking shogaols-induced G(2)/M cell cycle arrest to apoptosis characterized by caspase 3 and PARP cleavage were investigated. At sublethal concentrations, the halt at G(2)/M phase was alleviated along time and cells survived. Conversely, proapoptotic concentrations of 4- and 6-shogaol induced irreversible G(2)/M arrest that was at least in part associated with down-regulation of cell cycle checkpoint proteins cdk1, cyclin B and cdc25C, as well as spindle assembly checkpoint proteins mad2, cdc20 and survivin. A dose- and time-dependent accumulation of insoluble tubulin in the insoluble fractions of cell lysates provided evidence that G(2) checkpoint failure led to disruption of microtubule turnover. In summary, our results conclude that shogaols cause apoptosis by inducing aberrant mitosis at least through the attenuation of cell cycle and spindle assembly checkpoint proteins.
Insights
Shogaols, particularly 4- and 6-shogaol, effectively inhibit cancer cell growth by disrupting microtubule function and inducing apoptosis. These compounds trigger irreversible G(2)/M cell cycle arrest, leading to programmed cell death in colon and neuroblastoma cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Shogaols are known to induce cancer cell death through various mechanisms.
- 6-Shogaol has been previously shown to damage microtubules by reacting with tubulin sulfhydryl groups.
Purpose of the Study:
- To synthesize and evaluate antiproliferative activity of shogaols with varying side chain lengths.
- To investigate the molecular mechanisms underlying shogaol-induced apoptosis in cancer cells.
Main Methods:
- Synthesis of 4-, 6-, 8-, and 10-shogaol.
- Antiproliferative assays in HCT 116 colon carcinoma and SH-SY5Y neuroblastoma cells.
- Soft agar assays for anchorage-independent growth.
- Analysis of cell cycle progression, apoptosis markers (caspase 3, PARP), and checkpoint proteins (cdk1, cyclin B, cdc25C, mad2, cdc20, survivin).
- Assessment of tubulin solubility to evaluate microtubule disruption.
Main Results:
- 4- and 6-shogaol exhibited the strongest antiproliferative activity.
- Shogaols inhibited cancer cell colony formation in soft agar assays.
- Proapoptotic concentrations of 4- and 6-shogaol induced irreversible G(2)/M cell cycle arrest.
- This arrest was linked to the downregulation of cell cycle and spindle assembly checkpoint proteins.
- Evidence of disrupted microtubule turnover was observed through tubulin accumulation.
Conclusions:
- Shogaols induce apoptosis in cancer cells by causing aberrant mitosis.
- The mechanism involves the attenuation of cell cycle and spindle assembly checkpoint proteins.
- 4- and 6-shogaol are promising lead compounds for cancer therapy due to their antiproliferative and apoptotic effects.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Abnormal Proliferation
Negative Regulator Molecules
Microtubule Instability
